[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-295646-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-295646-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","aragen-life-sciences-limited-corporate-identity-number-and-offer-details","ARAGEN LIFE SCIENCES LIMITED - Corporate Identity Number and Offer Details","","ARAGEN LIFE SCIENCES LIMITED provides corporate identity and registered office contact information, identifies promoters and selling shareholders, and describes offer terms for the public. The content outlines the fresh issue and offer for sale structure, including equity share quantities, face value, and eligibility/reservation references under SEBI ICDR Regulations, 2018. It also sets out general risk disclosures for investors, noting the absence of prior formal market and the limits of assurance regarding trading and pricing after listing.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/aragen-life-sciences-limited-corporate-identity-number-and-offer-details/295646/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/aragen-life-sciences-limited-corporate-identity-number-and-offer-details/295646.png","ImageObject",300,407,{"name":42,"@type":43},"\tJames","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-18",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is ARAGEN LIFE SCIENCES LIMITED’s corporate registration and contact information?","Question",{"text":63,"@type":64},"The document lists the corporate identity number, registered/corporate office address in Hyderabad, and a company secretary contact including email and telephone, plus the website.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the document describe the offer to the public?",{"text":68,"@type":64},"It specifies the offer type as a fresh issue and offer for sale, sets equity face value, provides offer size ranges, and references eligibility and reservation under SEBI ICDR Regulations, 2018.",{"name":70,"@type":61,"acceptedAnswer":71},"What risks are disclosed for investors in relation to this first public offer?",{"text":72,"@type":64},"It states that there has been no formal market prior to the offer, investments involve risk, bidders should review risk factors carefully, and there is no guarantee of active or sustained trading or the post-listing price.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},295646,1789721184,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":80,"read_time":145,"preview_page_count":4},2336474466412,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","ARAGEN LIFE SCIENCES LIMITED Corporate Identity Number: U74999TG2000PLC035826  \n\n| REGISTERED AND CORPORATE OFFICE |  | CONTACT PERSON |  | EMAIL AND TELEPHONE | WEBSITE |\n| --- | --- | --- | --- | --- | --- |\n| Plot 28A, IDA Nacharam Hyderabad 500 076 Telangana, India |  | Ramakrishna Kasturi\u003Cbr>Company Secretary and Compliance Officer |  | E-mail:\u003Cbr>compliances@aragen.com\u003Cbr>Tel: +91 40 6692 9999 | [www.aragen.com](www.aragen.com) |\n| THE PROMOTERS OF OUR COMPANY ARE DAVINDER SINGH BRAR, REDDY INVESTMENT TRUST, MADHUBANI INVESTMENTS PRIVATE LIMITED, APARNA REDDY GUNAPATI, AND KESHAV\u003Cbr>GUNUPATI VENKAT REDDY |  |  |  |  |  |\n| DETAILS OF THE OFFER TO THE PUBLIC |  |  |  |  |  |\n| TYPE | FRESH ISSUE SIZE | SIZE OF THE OFFER FOR SALE | TOTAL OFFER SIZE^^ | ELIGIBILITY AND RESERVATION |  |\n| Fresh Issue\u003Cbr>and Offer for Sale | Up to [●]\u003Cbr>Equity Shares\u003Cbr>of face value\u003Cbr>of ₹ 10 each\u003Cbr>aggregating up\u003Cbr>to ₹ 8,000 .00 million | Up to\u003Cbr>27,329,192 Equity Shares\u003Cbr>of face value\u003Cbr>of ₹10 each\u003Cbr>aggregating up\u003Cbr>to ₹ [●] million | [●] Equity\u003Cbr>Shares of face\u003Cbr>value of ₹10 each aggregating up\u003Cbr>to ₹ [●] million | The Offer is being made pursuant to Regulation 6(1) of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”) . For further details, see “Other Regulatory and Statutory Disclosures – Eligibility for the Offer”on page 494. For details in relation to the share allocation and reservation among, Qualified Institutional Buyers (“QIBs”), Retail Individual Bidders (“RIBs”), Non-Institutional Bidders (“NIBs”) and Eligible Employees, see “Offer Structure” on page 516. |  |\n| DETAILS OF THE OFFER FOR SALE BY THE SELLING SHAREHOLDERS |  |  |  |  |  |\n| NAME OF THE SELLING SHAREHOLDER |  | TYPE |  | NUMBER OF EQUITY SHARES OFFERED OF FACE VALUE OF ₹ 10 EACH / AMOUNT (IN ₹ MILLION) | WEIGHTED AVERAGE COST OF ACQUISITION (IN ₹ PER EQUITY SHARE)\u003Cbr>\\# |\n| Reddy Investment Trust(1) |  | Promoter Selling Shareholder |  | Up to 1,863,354 Equity Shares of face value of ₹10 each aggregating up to ₹ [●] million | 0.39 |\n| Davinder Singh Brar |  | Promoter Selling Shareholder |  | Up to 621,118 Equity Shares of face value of ₹10 each aggregating up to ₹ [●] million | 0.36 |\n| WSCPVIII (Singapore) Pte. Ltd. |  | Investor Selling Shareholder |  | Up to 18,460,361 Equity Shares of face value of ₹10 each aggregating up to ₹ [●] million | 293.79 |\n| WSCPVIII EMP (Singapore) Pte. Ltd. |  | Investor Selling Shareholder |  | Up to 3,323,006 Equity Shares of face value of ₹10 each aggregating up to ₹ [●] million | 283.23 |\n| Goldman Sachs Capital Holdings III Pte. Ltd. |  | Investor Selling Shareholder |  | Up to 2,565,193 Equity Shares of face value of ₹10 each aggregating up to ₹ [●] million | 283.23 |\n| WSCPVIII Parallel\u003Cbr>Intermediary (Singapore) Pte. Ltd. |  | Investor Selling Shareholder |  | Up to 496,160 Equity Shares of face value of ₹10 each aggregating up to ₹ [●] million | 289.13 |\n| \\#As certified by Agarwal & Ladda, Chartered Accountants (FRN: 012510S), by way of their certificate dated August 26, 2026.(1)Acting through its managing trustee, Aparna Reddy Gunapati. For further details in relation to Reddy Investment Trust, see“Our Promoters and Promoter Group – Details ofthe Promoter Trust” on page 314. |  |  |  |  |  |\n| RISKS IN RELATION TO THE FIRST OFFER |  |  |  |  |  |\n| This being the first public offer of Equity Shares of our Company, there has been no formal market for the Equity Shares. The face value of the Equity Shares is ₹10 each. The Floor Price, Cap Price and Offer Price as determined by our Company, in consultation with the BRLMs, in accordance with the SEBI ICDR Regulations, and on the basis of assessment of market demand for the Equity Shares by way of the Book Building Process, as stated in “Basis for Offer Price” beginning on page 156 should not |  |  |  |  |  |\n\n\n| be considered to be indicative of the market price of","cbCaitbYkvguVQXJ","https://ap.wps.com/l/cbCaitbYkvguVQXJ","pdf",8356555,593,"English","# Offer to the Public\n## Details of the Offer to the Public\n## Details of the Offer for Sale by the Selling Shareholders\n# Risks and Responsibility Disclosures\n## Risks in Relation to the First Offer\n## General Risk\n## Company’s and the Selling Shareholders’ Absolute Responsibility","[{\"question\":\"What is ARAGEN LIFE SCIENCES LIMITED’s corporate registration and contact information?\",\"answer\":\"The document lists the corporate identity number, registered/corporate office address in Hyderabad, and a company secretary contact including email and telephone, plus the website.\"},{\"question\":\"How does the document describe the offer to the public?\",\"answer\":\"It specifies the offer type as a fresh issue and offer for sale, sets equity face value, provides offer size ranges, and references eligibility and reservation under SEBI ICDR Regulations, 2018.\"},{\"question\":\"What risks are disclosed for investors in relation to this first public offer?\",\"answer\":\"It states that there has been no formal market prior to the offer, investments involve risk, bidders should review risk factors carefully, and there is no guarantee of active or sustained trading or the post-listing price.\"}]","ARAGEN LIFE SCIENCES LIMITED - Corporate Identity Number and Offer Details | PDF",1494]